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Abstract 
    The actions and responses of hypothalamic appetite regulatory and factors change 
markedly during the neonatal to pre-pubertal period. Pituitary adenylate cyclase-
activating polypeptide (PACAP) has been found to play pivotal roles in the regulation of 
metabolic and nutritional status through its specific receptor PAC1. PACAP/PAC1 have 
anorectic roles, and their functions are regulated by leptin in adulthood. In the present 
study, we showed that hypothalamic PACAP mRNA expression decreases during the 
neonatal to pre-pubertal period (from postnatal day 10 to 30) in both male and female rats. 
During this period, hypothalamic PACAP mRNA expression was not affected by 24 h 
fasting in either sex, while the serum leptin levels (leptin is a positive regulator of 
hypothalamic PACAP expression in adulthood) of both sexes were decreased by fasting. 
On the other hand, hypothalamic PAC1 mRNA expression did not change during the 
neonatal to pre-pubertal period in either sex; however, its levels were consistently higher 
in males than in females. Hypothalamic PAC1 mRNA expression was decreased by 24 h 
fasting in males, but no such changes were observed in females. These results indicate 
while hypothalamic PACAP expression is sensitive to a negative energy state and the 
serum leptin level in adulthood, no such relationships are seen in the pre-pubertal period. 
In addition, we speculate that differences in the gonadal steroidal milieu might induce 
sexual dimorphism in the basal hypothalamic PAC1 mRNA level and its response to 
fasting. The mechanisms responsible for and the physiological effects of such changes in 
hypothalamic PACAP and PAC1 expression during the developmental period remain to 
be clarified. 
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1. Introduction 
    Many physiological functions develop rapidly during the neonatal to pre-
pubertal period. In particular, the actions and responses of hypothalamic appetite-
regulating factors change markedly during this period in order to maintain an 
appropriate metabolic and nutritional state (Iwasa et al., 2015). Our previous studies 
have shown that the basal expression levels of some hypothalamic orexigenic and 
anorexigenic factors and their responses to fasting change during the neonatal to pre-
pubertal period and that these changes differ between males and females (Iwasa et al., 
2014, 2015). These results indicate that the roles of such hypothalamic factors in the 
regulation of metabolic and nutritional status during the neonatal to juvenile period 
might differ between the sexes. 
    Pituitary adenylate cyclase-activating polypeptide (PACAP), which was 
originally identified in the ovine hypothalamus (Miyata et al., 1989), has been found 
to play pivotal roles in the regulation of metabolic and nutritional status through its 
specific receptor PAC1 (Morley et al., 1992; Chance et al., 1995; Moro & Lerner, 
1997; Adams et al., 2008). The central injection of PACAP suppresses appetite and 
feeding (Morley et al., 1992; Chance et al., 1995), and increases core body 
temperature and locomotor activity (Resch et al., 2011). In addition, PACAP knockout 
mice exhibit marked reductions in core body temperature (Gray et al., 2002), and 
PAC1-deficient mice develop hyperinsulinemia in fed conditions (Jamen et al., 2000). 
The effects of PACAP on energy homeostasis are mainly mediated by two 
hypothalamic nuclei, the ventromedial nucleus (VMN) and the paraventricular 
nucleus (PVN) (Resch et al., 2013). Extremely high PACAP mRNA expression is seen 
in the hypothalamic VMN, and the PACAP-positive neurons in the VMN project into 
the PVN. PACAP-positive neurons from other brain sites, including the 
extrahypothalamic area, also project into the VMN and PVN; i.e., the VMN receives 
such projections from the medial amygdala and lateral parabrachial nucleus (LPB), 
whereas the PVN receives such projections from the bed nucleus of the stria 
terminalis and the LPB (Resch et al., 2013). Although the injection of PACAP into 
the PVN or VMN results in reduced overall food intake, meal patterns are affected by 
the injection of PACAP into the PVN, but not the VMN (Resch et al., 2013). On the 
other hand, the injection of PACAP into the VMN increases core body temperature 
and locomotor activity, but no such effects are seen after the injection of PACAP into 
4 
the PVN (Resch et al., 2013). PAC1 mRNA expression is widely distributed, with 
abundant expression seen in the hypothalamic nuclei, and the co-administration of a 
PAC1 antagonist into the PVN and VMN abrogated the effects of the injection of 
PACAP into these sites (Resch et al., 2013). These results indicate that PACAP 
signaling within the PVN induces hypophagia, while PACAP signaling within the 
VMN stimulates energy expenditure. 
 Recently, it has been reported that hypothalamic PACAP in the VMN is a target of 
central leptin signaling. For example, the anorectic actions of leptin are abolished in 
PAC1-deficient mice (Vu et al., 2015) and PACAP knockout mice (Tanida et al., 2013). 
In addition, PACAP mRNA expression in the VMN is reduced in leptin knockout 
mice and increased by the administration of leptin (Hawke et al., 2009). It has also 
been reported that PACAP mRNA expression fell during fasting, but rose after the 
administration of a high-fat diet (Takaki et al., 1992; Yokota et al., 1993). We 
speculate that, as has been found for other factors, the basal hypothalamic expression 
levels of PACAP and PAC1 and their responses to fasting change during development 
because the serum leptin level varies markedly during this period. In the present study, 
the developmental changes in hypothalamic PACAP and PAC1 mRNA expression and 
the serum leptin level were evaluated. In addition, the changes in the sensitivities of 
these factors to fasting that occur during the neonatal to pre-pubertal period were 
examined. 
     
2. Materials and Methods 
2.1. Animals 
    Pregnant Sprague-Dawley rats were purchased (Charles River Japan Inc., Tokyo, 
Japan) and housed under controlled lighting (14h light, 10h dark) and temperature 
(24°C) conditions. The day on which the pups were born was defined as postnatal day 
1. Twelve pups were randomly assigned to each dam on postnatal day 2. The rats were 
weaned at postnatal day 21 and housed at three or four per cage. Rats of both sexes 
were randomly selected from each dam on postnatal days 10, 20, and 30, and divided 
into the fed and fasting groups (n = 8 per group). The rats in the fasting groups were 
subjected to 24 h maternal (postnatal day 10 and 20) or food (postnatal day 30) 
deprivation. Twenty-four hours later (between 0900 and 1000), the rats’ brains and 
serum were collected by decapitation and stored at −80˚C and −20˚C, respectively. All 
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animal experiments were conducted in accordance with the ethical standards of the 
animal care and use committee of the University of Tokushima. 
2.2. Hormone assay and quantitative real-time polymerase chain reaction 
    The rats’ serum leptin levels were measured using a 125I-radioimmunoassay 
(RIA) kit (multi-species leptin RIA kit, Linco Research Inc., MO, USA). Whole 
hypothalamic explants were dissected from the frozen brains, as described previously 
(Iwasa et al., 2015; Munkhzaya et al., 2015). Total RNA was isolated using a TRIzol® 
reagent kit (Invitrogen Co., Carlsbad, CA, USA) and an RNeasy mini kit® (Qiagen 
GmBh, Hilden, Germany). Five μg of total RNA were used for the cDNA synthesis. 
cDNA was synthesized with oligo (deoxythymidine) primers at 50 °C using the 
SuperScript III first-strand synthesis system for the real-time polymerase chain 
reaction (PCR; Invitrogen Co.). The PCR analysis was performed using the 
StepOnePlusTM real-time PCR system (PE Applied Biosystems, Foster City, CA, 
USA). Standard curves, which were generated by serially diluting an abundant sample 
at least 4 times, were used for the relative quantification of each mRNA expression 
level. The mRNA expression levels of PACAP and PAC1 were normalized to that of 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH). The following forward and 
reverse primers were used: PACAP: F: 5’- CAT GTG TAG CGG AGC AAG GTT -3’, 
R: 5’- GTC TTG CAG CGG GTT TCC -3’; PAC1: F: 5’- GGT GCT TGA AGT CCA 
TAG TG -3’, R: 5’- CTT GTA CAG AAG CTG CAG TC -3’; GAPDH: F: 5’- ATG 
GCA CAG TCA AGG CTG AGA -3’, R: 5’- CGC TCC TGG AAG ATG GTG AT- 3’. 
The PCR cycling conditions were as follows: initial denaturation and enzyme 
activation at 95 °C for 10 min, followed by 45 cycles of denaturation at 95 °C for 15 
s; annealing at 56 °C for 30 s (PAC1), 64 °C for 30 s (PACAP), or 65 °C for 30 s 
(GAPDH); and extension at 72 °C for 1 min. There are three isoforms of PAC1 (Zhou 
et al., 1999), and the PAC1 primer used in this study was able to amplify all of these 
isoforms (Zhou et al., 1999; Basille et al., 2000). In this study, GAPDH mRNA 
expression was not affected by development or fasting in either sex. In addition, its 
expression did not differ between the sexes at any of the examined ages. 
2.3. Statistical analyses 
    All data are presented as mean ± SEM values. The statistical analyses were 
performed using one-way or two-way analysis of variance (ANOVA), or the Kruskal-
Wallis test together with the Tukey-Kramer or Steel-Dwass post-hoc test for 
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comparisons between the age groups. The Student’s t test or Mann–Whitney U test 
were used for comparisons between the sexes, or between the rats kept under the fed 
and fasted conditions. Statistical significance was defined as P <0.05. 
3. Results 
3.1. Developmental changes in hypothalamic PACAP and PAC1 mRNA expression 
and the serum leptin level under the fed conditions in male and female rats 
    Under the fed conditions, the hypothalamic PACAP mRNA expression level 
differed significantly among the examined age groups in both the male (one-way 
ANOVA; F(3,47) = 32.9, P <0.01) and female rats (Kruskal-Wallis; df = 2, H = 18.5, 
P <0.01) (Fig. 1A). Hypothalamic PACAP mRNA expression fell with aging in both 
the male and female rats, but no difference in hypothalamic PACAP mRNA expression 
was detected between the sexes in any age group. The hypothalamic PAC1 mRNA 
expression level differed significantly among the examined age groups in the male rats 
(Kruskal-Wallis; df = 2, H = 10.4, P <0.01); however, post-hoc analyses did not find 
any significant differences among the age groups (Fig. 1B). On the other hand, 
hypothalamic PAC1 mRNA expression did not differ among the examined age groups 
in the females (Fig. 1B). Hypothalamic PAC1 mRNA expression was significantly 
higher in the males than in the females in all age groups (Fig. 1B). The serum leptin 
level differed significantly among the age groups in both the males (one-way ANOVA; 
F(3,47) = 22.4, P <0.01) and females (one-way ANOVA; F(3,47) = 13.4, P <0.01) (Fig. 
1C). The serum leptin levels recorded on postnatal day 10 were higher than those seen 
on postnatal days 20 and 30 in both the males and females. No significant correlations 
were detected between the serum leptin level and the hypothalamic PACAP mRNA 
level on day 10, 20, or 30 in either sex. Similarly, there were no significant correlations 
between the serum leptin level and the hypothalamic PAC1 mRNA level in either sex. 
3.2.  Effects of 24 h fasting on hypothalamic PACAP and PAC1 mRNA expression 
in male and female rats 
    Hypothalamic PACAP mRNA expression did not differ between the fed and 
fasted groups at any age in the male or female rats (Figs. 2A and D). In the male rats, 
the hypothalamic PAC1 mRNA expression levels of the fasted groups were 
significantly lower than those of the fed groups at all examined ages (Fig. 2B). On the 
other hand, hypothalamic PAC1 mRNA expression did not differ between the fed and 
fasted groups at any age in the female rats (Fig. 2E). The serum leptin levels of the 
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fasted groups were significantly lower than those of the fed groups at all examined 
ages in both the males and females (Figs. 2C and F). 
4. Discussion 
    In the present study, we showed that hypothalamic PACAP mRNA expression 
decreased during development in both male and female rats. Although the rats’ serum 
leptin levels also tended to fall during the developmental period, the pattern of change 
in hypothalamic PACAP expression did not correspond with that of the serum leptin 
level. In addition, although fasting caused reductions in the serum leptin level in both 
sexes at all examined ages, it did not affect hypothalamic PACAP mRNA expression. 
    It has been reported that leptin signaling via the leptin receptor (OBRb) is 
required for normal PACAP mRNA expression in the hypothalamus, and the central 
injection of an PACAP antagonist markedly reduced leptin-induced hypophagia and 
hyperthermia in adult male mice (Hawke et al., 2009). In addition, hypothalamic 
PACAP mRNA expression was reduced by 48 h food deprivation, but no such 
reduction was observed when leptin was simultaneously administered during food 
deprivation in adult male mice (Hawke et al., 2009). As hypothalamic PACAP 
functions as an anorexigenic and catabolic factor (Moro & Lerner, 1997), the reduction 
in PACAP activity induced by decreased leptin signaling during fasting might 
represent a compensatory response aimed at promoting feeding behavior and 
improving the energy balance in adulthood. On the other hand, in the present study 
although the serum leptin level was decreased by fasting in both sexes, hypothalamic 
PACAP mRNA expression was not affected by fasting in either sex. These results 
indicate that the relationship between the serum leptin level and hypothalamic PACAP 
expression observed in adulthood has not been established by the pre-pubertal period. 
It has been reported that during the pre-pubertal period leptin does not reduce food 
intake as markedly as it does in adulthood (Proulx et al., 2002). It is possible that 
during the pre-pubertal period the fact that PACAP is not very sensitive to the serum 
leptin level might blunt the effects of leptin on feeding behavior. This hypothesis could 
be tested by injecting leptin into animals during the pre-pubertal period and comparing 
their PACAP and PAC1 expression levels with those seen in adult animals. We 
speculate that the reduction in PACAP mRNA expression that occurred during 
development in both sexes, the fact that no fasting-induced changes in PACAP mRNA 
expression were observed in either sex, and the reduction in PAC1 mRNA expression 
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seen during fasting in male rats might be involved in the physiological mechanisms 
responsible for maintaining appetite and promoting growth in the pre-pubertal period. 
It has been reported that pituitary PACAP and PAC1 mRNA expression are regulated 
by gonadal steroids (Zheng et al., 2014). Thus, we also speculate that differences in 
the gonadal steroidal milieu might be responsible for the sexual dimorphism in 
hypothalamic PAC1 mRNA levels seen under basal and fasted conditions in the present 
study. 
    In the present study, hypothalamic PAC1 mRNA expression did not change 
during the developmental period in male or female rats; however, the male rats 
exhibited significantly higher hypothalamic PAC1 mRNA expression levels than the 
females at all examined ages. In addition, hypothalamic PAC1 mRNA expression was 
decreased by fasting in the male rats at all examined ages, whereas it was not affected 
by fasting at any of the examined ages in the female rats. Large variations in 
hypothalamic PAC1 mRNA expression were seen in the female rats under both the fed 
and fasted conditions. We could not identify the reason why such large variations were 
observed in the female rats in this study. As the basal serum leptin level and the fasting-
induced changes in the serum leptin level did not differ between the sexes, the sex-
related differences in hypothalamic PAC1 expression were probably not caused by 
dimorphism in the actions of leptin. Instead, we speculate that differences in the 
gonadal steroidal milieu might be responsible for the observed sexual dimorphism in 
the basal hypothalamic mRNA expression level of PAC1 and its response to fasting 
because the expression levels of some other appetite-regulating factors are regulated 
by gonadal steroids (Hirschberg, 2012). However, as far as we know, no previous study 
has examined the relationship between gonadal steroids and the hypothalamic 
PACAP/PAC1 system, and further examinations are needed to confirm our hypothesis. 
    The present study had several limitations. As whole hypothalamic blocks were 
used for the mRNA expression level measurements, the changes in mRNA expression 
seen in each hypothalamic nucleus; i.e., the VMN and PVN, could not be evaluated. 
Therefore, we could not clarify which site (or both) was responsible for the changes in 
PACAP/PAC1 mRNA expression observed during development and fasting in this 
study. Further examinations, for example, in situ hybridization, would be useful for 
identifying these specific sites. 
    In summary, we showed that hypothalamic PACAP mRNA expression decreased 
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during the neonatal to pre-pubertal period in both male and female rats. However, 
hypothalamic PACAP mRNA expression was not affected by 24 h fasting in either sex 
during the study period. In adulthood, hypothalamic PACAP mRNA expression is 
sensitive to a negative energy status and the serum leptin level, but it appears that no 
such relationship exists in the pre-pubertal period. Hypothalamic PAC1 mRNA 
expression did not change during the neonatal to pre-pubertal period in either sex; 
however, it was consistently higher in males than in females. The hypothalamic PAC1 
mRNA expression level fell after 24 h fasting in male rats, but no such changes were 
observed in the females. Differences in the gonadal steroidal milieu might be 
responsible for this sexual dimorphism. The mechanisms responsible for and the 
physiological effects of the changes in hypothalamic PACAP and PAC1 mRNA 
expression in the developmental period remain to be clarified. 
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Figure legends 
Fig. 1. 
Hypothalamic mRNA expression levels of PACAP (A) and PAC1 (B) and the serum leptin 
levels (C) observed under the fed conditions on postnatal days 10, 20, and 30 in male (■) 
and female (□) rats (n = 8 per group). Data are expressed as mean ± SE values. All 
mRNA expression levels were normalized to the mRNA expression level of GAPDH, and 
the values seen on postnatal day 10 male were defined as 1.0. Values with different letters 
(a-c) are significantly different (P <0.05). ** P <0.01 vs. each other.  
 
Fig. 2. 
Effects of 24 h maternal or food deprivation on the hypothalamic mRNA expression 
levels of PACAP (A, D) and PAC1 (B, E) and the serum leptin level (C, F) on postnatal 
days 10, 20, and 30 in male and female rats (□ fed, ■ fast, n = 8 per group). Data are 
expressed as mean ± SE values. All mRNA expression levels were normalized to the 
mRNA expression level of GAPDH, and the values seen in the fed groups on each day 
were defined as 1.0. * P <0.05, ** P <0.01 vs. each other. 
0.0 	
0.2 	
0.4 	
0.6 	
0.8 	
1.0 	
1.2 	
day10	
day20	
day30	
PACAP mRNA/GAPDH (relative fold)
0.0 	
0.5 	
1.0 	
1.5 	
2.0 	
2.5 	
day10	
day20	
day30	
PAC1 mRNA/GAPDH (relative fold)
male
female
Fig. 1
(A)
(B)
0.0 	
1.0 	
2.0 	
3.0 	
4.0 	
5.0 	
6.0 	
7.0 	
8.0 	
9.0 	
day10	
day20	
day30	
Serum leptin (ng/mL) (C)
a
b
c
a
b
c
**
**
**
a
b
b
a
b
b
Fig. 2
0.0 	
0.2 	
0.4 	
0.6 	
0.8 	
1.0 	
1.2 	
1.4 	
day10	
day20	
day30	
*
PAC1 mRNA/GAPDH (relative fold)
0.0 	
0.2 	
0.4 	
0.6 	
0.8 	
1.0 	
1.2 	
1.4 	
1.6 	
day10	
day20	
day30	
PAC1 mRNA/GAPDH (relative fold)
male
female
0.0 	
0.2 	
0.4 	
0.6 	
0.8 	
1.0 	
1.2 	
1.4 	
day10	
day20	
day30	
PACAP mRNA/GAPDH (relative fold)
0.0 	
0.2 	
0.4 	
0.6 	
0.8 	
1.0 	
1.2 	
1.4 	
day10	
day20	
day30	
PACAP mRNA/GAPDH (relative fold)
0.0 	
1.0 	
2.0 	
3.0 	
4.0 	
5.0 	
6.0 	
7.0 	
8.0 	
9.0 	
day10	
day20	
day30	
Serum leptin (ng/mL)
0.0 	
1.0 	
2.0 	
3.0 	
4.0 	
5.0 	
6.0 	
7.0 	
day10	
day20	
day30	
Serum leptin (ng/mL)
(A)
(B)
(C)
(D)
(E)
(F)
fed
fast
*
**

**

**

**

**

**

**

